Four years after Sanofi shelled out $125 million for global rights to Biond Biologic | The company is handing back the tumor ...
SALT LAKE CITY, Feb. 28, 2025 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX) a leading clinical stage TechBio company decoding ...
A special purpose acquisition company is a company formed to raise money through an initial public offering so it can later purchase or merge with an existing company. Special purpose acquisition ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback